Abstract
Although hundreds of genome-wide association studies-implicated loci have been reported for adult obesity-related traits, less is known about the genetics specific for early-onset obesity and with only a few studies conducted in non-European populations to date. Searching for additional genetic variants associated with childhood obesity, we performed a trans-ancestral meta-analysis of 30 studies consisting of up to 13 005 cases (≥95th percentile of body mass index (BMI) achieved 2-18 years old) and 15 599 controls (consistently <50th percentile of BMI) of European, African, North/South American and East Asian ancestry. Suggestive loci were taken forward for replication in a sample of 1888 cases and 4689 controls from seven cohorts of European and North/South American ancestry. In addition to observing 18 previously implicated BMI or obesity loci, for both early and late onset, we uncovered one completely novel locus in this trans-ancestral analysis (nearest gene, METTL15). The variant was nominally associated with only the European subgroup analysis but had a consistent direction of effect in other ethnicities. We then utilized trans-ancestral Bayesian analysis to narrow down the location of the probable causal variant at each genome-wide significant signal. Of all the fine-mapped loci, we were able to narrow down the causative variant at four known loci to fewer than 10 single nucleotide polymorphisms (SNPs) (FAIM2, GNPDA2, MC4R and SEC16B loci). In conclusion, an ethnically diverse setting has enabled us to both identify an additional pediatric obesity locus and further fine-map existing loci.
Original language | English (US) |
---|---|
Pages (from-to) | 3327-3338 |
Number of pages | 12 |
Journal | Human molecular genetics |
Volume | 28 |
Issue number | 19 |
DOIs | |
State | Published - Oct 1 2019 |
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Genetics
- Genetics(clinical)
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Human molecular genetics, Vol. 28, No. 19, 01.10.2019, p. 3327-3338.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - A trans-ancestral meta-analysis of genome-wide association studies reveals loci associated with childhood obesity
AU - Bradfield, Jonathan P.
AU - Vogelezang, Suzanne
AU - Felix, Janine F.
AU - Chesi, Alessandra
AU - Helgeland, Øyvind
AU - Horikoshi, Momoko
AU - Karhunen, Ville
AU - Lowry, Estelle
AU - Cousminer, Diana L.
AU - Ahluwalia, Tarunveer S.
AU - Thiering, Elisabeth
AU - Boh, Eileen Tai Hui
AU - Zafarmand, Mohammad H.
AU - Vilor-Tejedor, Natalia
AU - Wang, Carol A.
AU - Joro, Raimo
AU - Chen, Zhanghua
AU - Gauderman, William J.
AU - Pitkänen, Niina
AU - Parra, Esteban J.
AU - Fernandez-Rhodes, Lindsay
AU - Alyass, Akram
AU - Monnereau, Claire
AU - Curtin, John A.
AU - Have, Christian T.
AU - McCormack, Shana E.
AU - Hollensted, Mette
AU - Frithioff-Bøjsøe, Christine
AU - Valladares-Salgado, Adan
AU - Peralta-Romero, Jesus
AU - Teo, Yik Ying
AU - Standl, Marie
AU - Leinonen, Jaakko T.
AU - Holm, Jens Christian
AU - Peters, Triinu
AU - Vioque, Jesus
AU - Vrijheid, Martine
AU - Simpson, Angela
AU - Custovic, Adnan
AU - Vaudel, Marc
AU - Canouil, Mickaël
AU - Lindi, Virpi
AU - Atalay, Mustafa
AU - Kähönen, Mika
AU - Raitakari, Olli T.
AU - Van Schaik, Barbera D.C.
AU - Berkowitz, Robert I.
AU - Cole, Shelley A.
AU - Voruganti, V. Saroja
AU - Wang, Yujie
AU - Highland, Heather M.
AU - Comuzzie, Anthony G.
AU - Butte, Nancy F.
AU - Justice, Anne E.
AU - Gahagan, Sheila
AU - Blanco, Estela
AU - Lehtimäki, Terho
AU - Lakka, Timo A.
AU - Hebebrand, Johannes
AU - Bonnefond, Amélie
AU - Grarup, Niels
AU - Froguel, Philippe
AU - Lyytikäinen, Leo Pekka
AU - Cruz, Miguel
AU - Kobes, Sayuko
AU - Hanson, Robert L.
AU - Zemel, Babette S.
AU - Hinney, Anke
AU - Teo, Koon K.
AU - Meyre, David
AU - North, Kari E.
AU - Gilliland, Frank D.
AU - Bisgaard, Hans
AU - Bustamante, Mariona
AU - Bonnelykke, Klaus
AU - Pennell, Craig E.
AU - Rivadeneira, Fernando
AU - Uitterlinden, André G.
AU - Baier, Leslie J.
AU - Vrijkotte, Tanja G.M.
AU - Heinrich, Joachim
AU - Sørensen, Thorkild I.A.
AU - Saw, Seang Mei
AU - Pedersen, Oluf
AU - Hansen, Torben
AU - Eriksson, Johan
AU - Widén, Elisabeth
AU - McCarthy, Mark I.
AU - Njølstad, Pål R.
AU - Power, Christine
AU - Hyppönen, Elina
AU - Sebert, Sylvain
AU - Brown, Christopher D.
AU - Järvelin, Marjo Riitta
AU - Timpson, Nicholas J.
AU - Johansson, Stefan
AU - Hakonarson, Hakon
AU - Jaddoe, Vincent W.V.
AU - Struan, F. A.
N1 - Funding Information: CHOP: The authors thank the network of primary care clinicians and the patients and families for their contribution to this project and to clinical research facilitated by the Pediatric Research Consortium [PeRC]-The Children’s Hospital of Philadelphia. R. Chiavacci, E. Dabaghyan, A. [Hope] Thomas, K. Harden, A. Hill, C. Johnson-Honesty, C. Drummond, S. Harrison, F. Salley, C. Gibbons, K. Lilliston, C. Kim, E. Frackelton, F. Mentch, G. Otieno, K. Thomas, C. Hou, K. Thomas and M.L. Garris provided expert assistance with genotyping and/or data collection and management. The authors would also like to thank S. Kristinsson, L.A. Hermannsson and A. Krisbjörnsson of Raförninn ehf for extensive software design and contributions. This research was financially supported by an Institute Development Award from the Children’s Hospital of Philadelphia, a Research Development Award from the Cotswold Foundation, the Daniel B. Burke Endowed Chair for Diabetes Research, the Children’s Hospital of Philadelphia Endowed Chair in Genomic Research and NIH grant R01 HD056465. Funding Information: HBCS: We thank all study participants as well as everybody involved in the Helsinki Birth Cohort Study. Helsinki Birth Cohort Study has been supported by grants from the Academy of Finland (JGE grant no. 129369, 129907, 135072, 129255 and 126775), the Finnish Diabetes Research Society, Samfundet Folkhälsan, Novo Nordisk Foundation, Finska Läkaresällskapet, Juho Vainio Foundation, Signe and Ane Gyllenberg Foundation, Liv och Hälsa, University of Helsinki and Ministry of Education. Funding Information: COPSAC2000: All funding received by COPSAC is listed on www.copsac.com. The Lundbeck Foundation (grant no. R16-A1694); The Ministry of Health (grant no. 903516); Danish Council for Strategic Research (grant no. 0603-00280B) and The Capital Region Research Foundation have provided core support to the COPSAC research center. Funding Information: ESSEN: We (J.H., A.H. and T.P.) thank the following sources for funding or research: the German Ministry for Education and Research (National Genome Research Net-Plus 01GS0820), the German Research Foundation (DFG; HI865/2-1), the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreements n◦245009 and n◦262055. Funding Information: MOBA: The Norwegian Mother and Child Cohort Study was supported by grants from the European Research Council (AdG #293574), the Bergen Research Foundation (‘Utilizing the Mother and Child Cohort and the Medical Birth Registry for Better Health’), Stiftelsen Kristian Gerhard Jebsen (Translational Medical Center), the University of Bergen, the Research Council of Norway (FRIPRO grant #240413), the Western Norway Regional Health Authority (Strategic Fund ‘Personalized Medicine for Children and Adults’) and Open Grants («Understanding infant weight biology through genomics and deep phenotyping» grant #912250) and the Norwegian Diabetes Foundation; the Research Council of Norway through its Centres of Excellence funding scheme (#262700), Better Health by Harvesting Biobanks (#229624) and The Swedish Research Council, Stockholm, Sweden (2015-02559), The Research Council of Norway, Oslo, Norway (FRIMEDBIO ES547711), March of Dimes (#21-FY16-121). The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract no N01-ES-75558), NIH/NINDS (grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1). Funding Information: SLS: The obesity component of the Santiago Longtiduainal Study (SLS) was funded by 5R01HL088309. The SLS genetic work was funded in part by a University of North Carolina Nutrition Research Institute internal pilot grant and AHA grant 15GRNT25880008. Other components of the SLS were funded by NICHD and NIDA. We would like to thank the participants and their family members from the SLS. Funding Information: Generation R: The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, the Rotterdam Homecare Foundation, Rotterdam and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR-MDC), Rotterdam. We gratefully acknowledge the contribution of children and parents, general practitioners, hospitals, midwives and pharmacies in Rotterdam. The generation and management of GWAS genotype data for the Generation R Study was done at the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, The Netherlands. We would like to thank Karol Estrada, Dr Tobias A. Knoch, Anis Abuseiris, Luc V. de Zeeuw and Rob de Graaf for their help in creating GRIMP, Big-GRID, MediGRID and Services@MediGRID/D-Grid (funded by the German Bundesministerium fuer Forschung und Technology; grants 01 AK 803 A-H, 01 IG 07015 G) for access to their grid computing resources. We thank Pascal Arp, Mila Jhamai, Mar-ijn Verkerk, Manoushka Ganesh, Lizbeth Herrera and Marjolein Peters for their help in creating, managing and QC of the GWAS database. Funding Information: NFBC: We thank Professor Paula Rantakallio (launch of NFBC1966 and initial data collection). We gratefully acknowledge the contributions of the participants in the Northern Finland Birth Cohort 1966 study and the Northern Finland Birth Cohort 1986. We also thank all the field workers and laboratory personnel for their efforts. NFBC1966 received financial support from University of Oulu grant no. 65354, Oulu University Hospital grant no. 2/97, 8/97, Ministry of Health and Social Affairs grant no. 23/251/97, 160/97, 190/97, National Institute for Health and Welfare, Helsinki grant no. 54121, Regional Institute of Occupational Health, Oulu, Finland grant no. 50621, 54231. NFBC1986 received financial support from EU QLG1-CT-2000-01643 (EUROBLCS) grant no. E51560, NorFA grant no. 731, 20056, 30167, USA/NIHH 2000 G DF682 grant no. 50945. M.W. was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633212. M.R.J. and S.S. are supported by H2020-633595 DynaHEALTH action and academy of Finland EGEA-project (285547). V.K. is supported by H2020-721567 CAPICE project. Funding Information: The ABCD study has been supported by grants from The Netherlands Organisation for Health Research and Development (ZonMW) and The Netherlands Heart Foundation. Genotyping was funded by the BBMRI-NL grant CP2013-50. Dr M.H.Z. was supported by BBMRI-NL (CP2013-50). Dr T.G.M.V. was supported by ZonMW (TOP 40-00812-98-11010). Funding Information: MEXICO: We thank the participants of this study for their contribution. This work was supported by the Consejo Nacional de Ciencia y Tecnología (CONACYT-México) with the grant SALUD-2013-C01-201471 (FONSECSSA/IMSS/ISSSTE). Computations were performed on the GPC supercomputer at the SciNet HPC Consortium, Canada. SciNet is funded by the Canada Foundation for Innovation under the auspices of Compute Canada, the Government of Ontario, Ontario Research Fund-Research Excellence and the University of Toronto. Funding Information: INMA: This study was funded by grants from Instituto de Salud Carlos III (CB06/02/0041, FIS PI041436, PI081151, PI041705, PS09/00432, FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213, 07/0314, 09/02647, PI06/0867, PI 07/0314 PI09/0009, PI 11/01007), Spanish Ministry of Science and Innovation (SAF2013-49108-R), European Commission (ENGAGE project and grant agreement HEALTH-F4-2007-201413), Fundació La Marató de TV3, Generalitat de Catalunya-CIRIT AGAUR 2014 SGR-1138, Conselleria de Sanitat Generalitat Valenciana. Part of the DNA extractions and genotyping was performed at the Spanish National Genotyping Centre (CEGEN-Barcelona). The authors would particularly like to thank all the participants for their generous collaboration. A full roster of the INMA Project Investigators can be found at http://www. proyectoinma.org/presentacion-inma/listado-investigadores/ en_listado-investigadores.html. Funding Information: CHS: The CHS was supported by the Southern California Environmental Health Sciences Center (grant P30ES007048); National Institute of Environmental Health Sciences (grants 5P01ES011627, ES021801, ES023262, P01ES009581, P01ES011627, P01ES022845, R01 ES016535, R03ES014046, P50 CA180905, R01HL061768, R01HL076647, R01HL087680 and RC2HL101651), the Environmental Protection Agency (grants RD83544101, R826708, RD831861 and R831845) and the Hastings Foundation. Funding Information: ALSPAC: We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. We would also like to acknowledge 23andMe for our genotyping collaboration. The UK Medical Research Council (Grant ref: 74882), the Wellcome Trust (Grant ref: 076467) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and JPB and SFAG will serve as guarantors for the contents of this paper. Funding Information: HOLBAEK: This study is part of the research activities in TARGET (The Impact of our Genomes on Individual Treatment Response in Obese Children, www.target.ku.dk), BIOCHILD (Genetics and Systems Biology of Childhood Obesity in India and Denmark, www.biochild.ku.dk) and the MicribLiver project funded by a grant from the Novo Nordisk Foundation (NNF15OC0016692). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation (grant number NNF18CC0034900) from the Novo Nordisk Foundation (www.metabol.ku.dk). The study is part of The Danish Childhood Obesity Biobank; ClinicalTrials.gov ID-no. NCT00928473, retrospectively registered June 25, 2009. Funding Information: FAMILY: We thank the participants of this study for their contribution. The FAMILY genetic study has been funded by the Heart and Stroke Foundation of Ontario (grant NA 7293 ‘Early genetic origins of cardiovascular risk factors’). D.M. is supported by a Canada Research Chair in Genetics of Obesity. Funding Information: Raine study: The Raine Study acknowledges the National Health and Medical Research Council (NHMRC) for their long-term contribution to funding the study over the past 29 years. Core Management of the Raine study has been funded by the University of Western Australia (UWA), Curtin University, the UWA Faculty of Medicine, Dentistry and Health Sciences, the Raine Medical Research Foundation, the Telethon Kids Institute, the Women’s and Infants Research Foundation, Edith Cowan University, Murdoch University and the University of Notre Dame. This study was supported by the National Health and Medical Research Council of Australia (grant numbers 572613, 403981 and 003209) and the Canadian Institutes of Health Research (grant number MOP-82893). The authors gratefully acknowledge the assistance of the Western Australian DNA Bank (National Health and Medical Research Council of Australia National Enabling Facility). All analytic work was supported by resources provided by the Pawsey Supercomputing Centre with funding from the Australian Government and the Government of Western Australia. Funding Information: YFS: The Young Finns Study has been financially supported by the Academy of Finland: grants 286284, 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland; Competitive State Research Financing of the Expert Responsibility area of Kuopio, Tampere and Turku University Hospitals (grant X51001); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; The Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association; EU Horizon 2020 (grant 755320 for TAXINOMISIS); European Research Council (grant 742927 for MULTIEPIGEN project); and Tampere University Hospital Supporting Foundation. Funding Information: PANIC: The PANIC Study has financially been supported by grants from Ministry of Education and Culture of Finland, Ministry of Social Affairs and Health of Finland, Research Committee of the Kuopio University Hospital Catchment Area (State Research Funding), Finnish Innovation Fund Sitra, Social Insurance Institution of Finland, Finnish Cultural Foundation, Foundation for Paediatric Research, Diabetes Research Foundation in Finland, Finnish Foundation for Cardiovascular Research, Juho Vainio Foundation, Paavo Nurmi Foundation, Yrjö Jahnsson Foundation and the city of Kuopio. Moreover, the PhD students and postdoctoral researchers of The PANIC Study have financially been supported by personal grants from the doctoral schools of Finnish universities and Finnish foundations. We are grateful to the members of the PANIC research team for their contribution in acquisition of data. We are also indebted to all children and their parents participating in the PANIC study. Funding Information: VIVA: The Viva la Familia Study was supported by the National Institutes of Health (NIH) (DK080457) and the USDA/ARS (Cooperative Agreement 6250-51000-053). Work performed at the Texas Biomedical Research Institute in San Antonio, Texas was conducted in facilities constructed with support from the Research Facilities Improvement Program of the National Center for Research Resources, NIH (C06 RR013556, C06 RR017515). Funding Information: This study received funding from the Innovation Fund Denmark [grant numbers 0603-00484B (TARGET) and 0603-00457B (BIOCHILD)] and The Novo Nordisk Foundation (grant numbers NNF15OC0016544, NNF15OC0016692 and NNF18CC0034900) and The Region Zealand Health Scientific Research Foundation. Funding Information: AI-AZ: American Indian studies were funded by the Intramural Program of NIDDK, NIH. Funding Information: MAAS: We would like to thank the children and their parents for their continued support and enthusiasm. We greatly appreciate the commitment they have given to the project. We would also like to acknowledge the hard work and dedication of the study team (post-doctoral scientists, research fellows, nurses, physiologists, technicians and clerical staff). This report includes independent research supported by National Institute for Health Research Respiratory Clinical Research Facility at Manchester University NHS Foundation Trust (Wythenshawe). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. MAAS was supported by the Asthma UK Grants No 301 (1995–1998), No 362 (1998– 2001), No 01/012 (2001–2004), No 04/014 (2004–2007), the BMA James Trust and Medical Research Council, UK (G0601361) and The Moulton Charitable Foundation (2004–current); the Medical Research Council (MRC) Grants G0601361, MR/K002449/1 and MR/L012693/1, and Angela Simpson is supported by the NIHR Manchester Biomedical Research Centre. The authors would like to acknowledge the North West Lung Centre Charity for supporting this project. Funding Information: The general design of Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), the Netherlands Organisation for Scientific Research (NWO), the Ministry of Health, Welfare and Sport and the Ministry of Youth and Families. V.W.J. received an additional grant from the Netherlands Organization for Health Research and Development (VIDI 016.136.361) and a Consolidator Grant from the European Research Council (ERC-2014-CoG-648916). FR received an additional grant from the Netherlands Organization for Health Research and Development (VIDI 016.136.367). This project received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements No 633595 (DynaHEALTH) and No 733206 (LifeCycle). Publisher Copyright: © 2019 The Author(s) 2019. Published by Oxford University Press. All rights reserved.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Although hundreds of genome-wide association studies-implicated loci have been reported for adult obesity-related traits, less is known about the genetics specific for early-onset obesity and with only a few studies conducted in non-European populations to date. Searching for additional genetic variants associated with childhood obesity, we performed a trans-ancestral meta-analysis of 30 studies consisting of up to 13 005 cases (≥95th percentile of body mass index (BMI) achieved 2-18 years old) and 15 599 controls (consistently <50th percentile of BMI) of European, African, North/South American and East Asian ancestry. Suggestive loci were taken forward for replication in a sample of 1888 cases and 4689 controls from seven cohorts of European and North/South American ancestry. In addition to observing 18 previously implicated BMI or obesity loci, for both early and late onset, we uncovered one completely novel locus in this trans-ancestral analysis (nearest gene, METTL15). The variant was nominally associated with only the European subgroup analysis but had a consistent direction of effect in other ethnicities. We then utilized trans-ancestral Bayesian analysis to narrow down the location of the probable causal variant at each genome-wide significant signal. Of all the fine-mapped loci, we were able to narrow down the causative variant at four known loci to fewer than 10 single nucleotide polymorphisms (SNPs) (FAIM2, GNPDA2, MC4R and SEC16B loci). In conclusion, an ethnically diverse setting has enabled us to both identify an additional pediatric obesity locus and further fine-map existing loci.
AB - Although hundreds of genome-wide association studies-implicated loci have been reported for adult obesity-related traits, less is known about the genetics specific for early-onset obesity and with only a few studies conducted in non-European populations to date. Searching for additional genetic variants associated with childhood obesity, we performed a trans-ancestral meta-analysis of 30 studies consisting of up to 13 005 cases (≥95th percentile of body mass index (BMI) achieved 2-18 years old) and 15 599 controls (consistently <50th percentile of BMI) of European, African, North/South American and East Asian ancestry. Suggestive loci were taken forward for replication in a sample of 1888 cases and 4689 controls from seven cohorts of European and North/South American ancestry. In addition to observing 18 previously implicated BMI or obesity loci, for both early and late onset, we uncovered one completely novel locus in this trans-ancestral analysis (nearest gene, METTL15). The variant was nominally associated with only the European subgroup analysis but had a consistent direction of effect in other ethnicities. We then utilized trans-ancestral Bayesian analysis to narrow down the location of the probable causal variant at each genome-wide significant signal. Of all the fine-mapped loci, we were able to narrow down the causative variant at four known loci to fewer than 10 single nucleotide polymorphisms (SNPs) (FAIM2, GNPDA2, MC4R and SEC16B loci). In conclusion, an ethnically diverse setting has enabled us to both identify an additional pediatric obesity locus and further fine-map existing loci.
UR - http://www.scopus.com/inward/record.url?scp=85075111079&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075111079&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddz161
DO - 10.1093/hmg/ddz161
M3 - Article
C2 - 31504550
AN - SCOPUS:85075111079
SN - 0964-6906
VL - 28
SP - 3327
EP - 3338
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 19
ER -